Serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease receiving anti-thyroid medication

被引:3
|
作者
Ashizawa, K
Eguchi, K
机构
[1] Nagasaki Univ, Sch Med, Atom Bomb Dis Inst, Dept Radiat Biophys,Radiat Effect Res Unit, Nagasaki 8528523, Japan
[2] Nagasaki Univ, Sch Med, Dept Internal Med 1, Nagasaki 8528501, Japan
关键词
anti-myeloperoxidase antineutrophil cytoplasmic; antibodies (MPO-ANCA); Graves' disease; propylthiouracil; CROSS-REACTIVITY; PROPYLTHIOURACIL; MYELOPEROXIDASE; GLOMERULONEPHRITIS; AUTOANTIBODIES; INVOLVEMENT; PREVALENCE; VASCULITIS; APPEARANCE; ABSENCE;
D O I
10.2169/internalmedicine.42.463
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:463 / 464
页数:2
相关论文
共 41 条
  • [1] Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole
    Wada, N
    Mukai, M
    Kohno, M
    Notoya, A
    Ito, T
    Yoshioka, N
    ENDOCRINE JOURNAL, 2002, 49 (03) : 329 - 334
  • [2] A Long-term Follow-up of Serum Myeloperoxidase Antineutrophil Cytoplasmic Antibodies (MPO-ANCA) in Patients with Graves Disease Treated with Propylthiouracil
    Ishii, Reiko
    Imaizumi, Misa
    Ide, Akane
    Sera, Nobuko
    Ueki, Ikuko
    Horie, Ichiro
    Ando, Takao
    Usa, Toshiro
    Ejima, Eri
    Ashizawa, Kiyoto
    Eguchi, Katsumi
    ENDOCRINE JOURNAL, 2010, 57 (01) : 73 - 79
  • [3] Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves disease treated with propylthiouracil
    Fujieda, M
    Suzuki, J
    Sato, H
    Hattori, M
    Wada, N
    Tsuchiya, M
    Okamoto, N
    Murata, T
    Matsudaira, M
    Shimizu, M
    Ohta, K
    Naruse, K
    Sugihara, S
    Wakiguchi, H
    CLINICAL NEPHROLOGY, 2005, 63 (06) : 437 - 445
  • [4] Development of a Certified Reference Material for myeloperoxidase-anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)
    Monogioudi, Evanthia
    Hutu, Dana Petronela
    Martos, Gustavo
    Sheldon, Joanna
    Schimmel, Heinz
    Meroni, Pier Luigi
    Zegers, Ingrid
    CLINICA CHIMICA ACTA, 2017, 467 : 48 - 50
  • [5] Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease
    Panamonta, Ouyporn
    Sumethkul, Vasant
    Radinahmed, Piyanuth
    Laopaiboon, Malinee
    Kirdpon, Wichitr
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2008, 21 (06) : 539 - 543
  • [6] Epitope Analysis of Anti-Myeloperoxidase Antibodies in Patients with ANCA-Associated Vasculitis
    Gou, Shen-Ju
    Xu, Peng-Cheng
    Chen, Min
    Zhao, Ming-Hui
    PLOS ONE, 2013, 8 (04):
  • [7] Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis
    Gao, Y
    Ye, H
    Yu, F
    Guo, XH
    Zhao, MH
    CLINICAL IMMUNOLOGY, 2005, 117 (01) : 87 - 93
  • [8] Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease - CT findings in 51 patients
    Ando, Y
    Okada, F
    Matsumoto, S
    Mori, H
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2004, 28 (05) : 710 - 716
  • [9] Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing
    Rao, Deepak A.
    Wei, Kevin
    Merola, Joseph F.
    O'Brien, William R.
    Takvorian, Samuel U.
    Dellaripa, Paul F.
    Schur, Peter H.
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (05) : 847 - 852
  • [10] Development of anti-neutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves' disease independent of anti-thyroid drug therapy
    Khan, Nasim Ahmed
    Singh, Manisha
    MODERN RHEUMATOLOGY, 2012, 22 (05) : 778 - 782